Federal and postal workers to see double-digit health care premium increases again next year

Federal and postal workers face substantial health care premium increases for 2026, marking the second consecutive year of double-digit hikes. Federal Employees Health Benefits Program (FEHBP) premiums for employees and retirees will rise by an average of 12.3%, with the overall program seeing a 10.2% increase, while Postal Service Health Benefits Program (PSHBP) premiums will climb 11.3%. The Office of Personnel Management (OPM) attributes some of these rising costs to new high-efficacy drugs like GLP-1s, expressing hope for future moderation through Trump administration initiatives on prescription drug pricing. These increases are drawing criticism from federal employee groups, who argue that, alongside a proposed 1% pay raise and ongoing government shutdown, they will negatively impact public service recruitment and retention.

Analysis

Federal and postal workers face significant health care premium increases for 2026, marking the second consecutive year of double-digit hikes. Federal Employees Health Benefits Program (FEHBP) enrollees will see their share rise by an average of 12.3%, contributing to an overall program increase of 10.2%. Similarly, Postal Service Health Benefits Program (PSHBP) premiums are set to climb by 11.3% on average, following an 11.1% increase in 2025. Dental and vision premiums will see more modest increases of 3.3% and 0.5% respectively.

The Office of Personnel Management (OPM) attributes some of these rising costs to the increased utilization of high-efficacy drugs, such as GLP-1s, which add substantially to short-term costs. OPM expresses optimism that future premium increases may subside due to anticipated efforts by the Trump administration to address prescription drug pricing, despite previous unsubstantiated claims of drastic reductions.

These premium hikes are drawing strong criticism from federal employee groups, including the National Active and Retired Federal Employees Association (NARFE). They argue that these increases, coupled with an ongoing government shutdown and a proposed 1% pay raise for non-law enforcement personnel, will significantly erode the appeal of public service. This cumulative impact is expected to negatively affect the federal government's ability to recruit and retain a qualified workforce.

Key Decisions for Investors

• Monitor healthcare cost trends, particularly the impact of high-efficacy drugs like GLP-1s, as sustained double-digit premium increases for federal employees highlight persistent inflation that could affect broader corporate benefit plans and healthcare sector profitability.
• Assess political and regulatory risks in the healthcare sector, as the article underscores the significant influence of presidential administrations on prescription drug pricing, indicating potential policy shifts that could impact pharmaceutical companies' revenue streams and margins.
• Evaluate labor market dynamics in the public sector, as the 'strongly negative' sentiment among federal workers due to rising costs and stagnant wages suggests potential challenges in public sector recruitment and retention, which could have long-term implications for government efficiency and service delivery.